Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1887014-12-1
Purity
95%
Olutasidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation as detected by an FDA-approved test.
Properties
Name
Olutasidenib
Smiles
C[C@H](NC1=CC=C(C#N)N(C)C1=O)C2=CC=3C=C(Cl)C=CC3NC2=O
Targets
Please log in to see this information
SDS
olutasidenib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$POA
2 mg
$POA
5 mg
$POA
10 mg
$POA
15 mg
$POA
20 mg
$POA
25 mg
$POA
30 mg
$POA
35 mg
$POA
40 mg
$POA
45 mg
$POA
50 mg
$POA
75 mg
$POA
100 mg
$POA
Quantity
1
Total amount
$ 0
olutasidenib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.